about
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include S...
Read More
2.36
0.05
(2.16%)
2.1M
XNAS Volume
XNAS 07 Nov, 2025 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Gossamer Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..